Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinpritma Sangha

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Vaccine|May 30, 2015
Bridging the gap: need for a data repository to support vaccine prioritization effortsGuruprasad Madhavan, Charles Phelps, Kinpritma Sangha, et al.
Hepatology (Baltimore, Md.)|June 10, 2023
Reply: Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional second-tier test?Kinpritma Sangha, Stephanie T Chang, Ramsey Cheung, et al.
Hepatology (Baltimore, Md.)|April 5, 2023
Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosisKinpritma Sangha, Stephanie T Chang, Ramsey Cheung, et al.
Hepatology (Baltimore, Md.)|May 11, 2023
Reply: Modeling concernsKinpritma Sangha, Stephanie T Chang, Ramsey Cheung, et al.
Journal of Health Economics|December 19, 2021
God is in the rain: The impact of rainfall-induced early social distancing on COVID-19 outbreaksAjay Shenoy, Bhavyaa Sharma, Guanghong Xu, et al.
Eclinicalmedicine|September 5, 2024
Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosisSzu-Yu Zoe Kao, Kinpritma Sangha, Naoto Fujiwara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2014
A priority-setting aid for new vaccine candidatesCharles Phelps, Guruprasad Madhavan, Kinpritma Sangha, et al.
Journal of Neurointerventional Surgery|September 29, 2022
Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic coreMaria X Sanmartin, Jeffrey M Katz, Jason Wang, et al.
The Journal of Applied Laboratory Medicine|January 15, 2025
Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran PopulationSamrat Yeramaneni, Stephanie T Chang, Ramsey C Cheung, et al.
Gastro Hep Advances|April 20, 2026
Cost-Effectiveness of Blood-Based Fibrosis Screening in High-Risk Metabolic Liver Diseases With Emerging TherapiesWanyi Chen, Stephanie T Chang, Ramsey C Cheung, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Vaccine|May 30, 2015
Bridging the gap: need for a data repository to support vaccine prioritization effortsGuruprasad Madhavan, Charles Phelps, Kinpritma Sangha, et al.
Hepatology (Baltimore, Md.)|June 10, 2023
Reply: Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional second-tier test?Kinpritma Sangha, Stephanie T Chang, Ramsey Cheung, et al.
Hepatology (Baltimore, Md.)|April 5, 2023
Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosisKinpritma Sangha, Stephanie T Chang, Ramsey Cheung, et al.
Hepatology (Baltimore, Md.)|May 11, 2023
Reply: Modeling concernsKinpritma Sangha, Stephanie T Chang, Ramsey Cheung, et al.
Journal of Health Economics|December 19, 2021
God is in the rain: The impact of rainfall-induced early social distancing on COVID-19 outbreaksAjay Shenoy, Bhavyaa Sharma, Guanghong Xu, et al.
Eclinicalmedicine|September 5, 2024
Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosisSzu-Yu Zoe Kao, Kinpritma Sangha, Naoto Fujiwara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2014
A priority-setting aid for new vaccine candidatesCharles Phelps, Guruprasad Madhavan, Kinpritma Sangha, et al.
Journal of Neurointerventional Surgery|September 29, 2022
Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic coreMaria X Sanmartin, Jeffrey M Katz, Jason Wang, et al.
The Journal of Applied Laboratory Medicine|January 15, 2025
Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran PopulationSamrat Yeramaneni, Stephanie T Chang, Ramsey C Cheung, et al.
Gastro Hep Advances|April 20, 2026
Cost-Effectiveness of Blood-Based Fibrosis Screening in High-Risk Metabolic Liver Diseases With Emerging TherapiesWanyi Chen, Stephanie T Chang, Ramsey C Cheung, et al.
Pageof 2